From: Preventable medication harm across health care settings: a systematic review and meta-analysis
Drug class | ATC code | N studies | Prevalence, % | 95% CI | Ï„2 | I2 (%) |
---|---|---|---|---|---|---|
Analgesics | N02Â¥ | 4 | 7 | 0.5, 19 | 0.0229 | 84.00 |
Antibiotics and antibacterial | J01Â¥ | 12 | 12 | 7, 18 | 0.0165 | 87.80 |
Antithrombotic agents/anticoagulants | B01Â¥ | 10 | 11 | 7, 15 | 0.0073 | 78.60 |
Antidepressants | N06Aβ | 4 | 6 | 0.4, 17 | 0.0253 | 94.90 |
Antidiabetic | A10Â¥ | 4 | 7 | 0.8, 17 | 0.0162 | 77.50 |
Antiepileptics | N03Â¥ | 3 | 4 | 0.2, 10 | 0.0029 | 26.40 |
Anti-inflammatory and antirheumatic | M01Â¥ | 5 | 15 | 7, 26 | 0.0166 | 79.40 |
Antipsychotics | N05Aβ | 4 | 11 | 0.2, 32 | 0.0622 | 95.60 |
Cardiovascular | C* | 14 | 16 | 11, 23 | 0.0205 | 90.80 |
Corticosteroids | H02Â¥ | 5 | 2 | 0.2, 6 | 0.0066 | 77.10 |
Diuretics | C03Â¥ | 5 | 6 | 0.2, 17 | 0.0365 | 95.80 |
Functional gastrointestinal disorders | A03Â¥ | 3 | 4 | 0, 14 | 0.0183 | 75.80 |
Musculoskeletal system | M* | 3 | 9 | 2.4, 20 | 0.0142 | 85.00 |
Nervous system | N* | 6 | 21 | 6, 43 | 0.0784 | 97.00 |
Opioids | N02Aβ | 5 | 6 | 2, 10 | 0.0045 | 74.70 |
Respiratory system-related drugs | R* | 4 | 1 | 0, 4 | 0.0061 | 74.90 |
Sedatives | N05Cβ | 5 | 16 | 11, 21 | 0.0016 | 33.50 |